{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:07Z","timestamp":1790698807383,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Government Research Training Program (RTP) Stipend and RTP Fee-Offset Scholarship through Federation University Australia"},{"name":"Swedish Research Council and the Swedish Children&apos;s Cancer Foundation"},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1144308"],"award-info":[{"award-number":["APP1144308"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002136","name":"Histiocytosis Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002136","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Langerhans cell histiocytosis (LCH) lesions are defined by the presence of CD1a<jats:sup>+<\/jats:sup>\/CD207<jats:sup>+<\/jats:sup> myeloid cells, but many other immune cells are present including unconventional T cells, which have powerful immunoregulatory functions. Unconventional T cell lineages include mucosal-associated invariant T (MAIT) cells, type I natural killer T (NKT) cells and gamma-delta (\u03b3\u03b4) T cells, which are associated with many inflammatory conditions, although their importance has not been studied in LCH. We characterized their phenotype and function in blood and lesions from patients with LCH, and identified a deficiency in MAIT cell frequency and abnormalities in the subset distributions of \u03b3\u03b4 T cells and NKT cells. Such abnormalities are associated with immune dysregulation in other disease settings and are therefore potentially important in LCH. Our study is the first to recognize alterations to MAIT cell proportions in patients with LCH. This finding along with other abnormalities identified amongst unconventional T cells could potentially influence the onset and progression of LCH, thereby highlighting potential targets for new immune based therapies.<\/jats:p>","DOI":"10.1038\/s41598-018-34873-y","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T15:55:28Z","timestamp":1541087728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Jen\u00e9e","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Kvedaraite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"von Bahr Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Pellicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart P.","family":"Berzins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kannourakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"34873_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ped.12380","volume":"56","author":"A Morimoto","year":"2014","unstructured":"Morimoto, A., Oh, Y., Shioda, Y., Kudo, K. & Imamura, T. Recent advances in Langerhans cell histiocytosis. Pediatr Int 56, 451\u2013461 (2014).","journal-title":"Pediatr Int"},{"key":"34873_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","volume":"126","author":"CE Allen","year":"2015","unstructured":"Allen, C. E., Ladisch, S. & McClain, K. L. How we treat Langerhans cell histiocytosis. Blood 126, 26\u201335 (2015).","journal-title":"Blood"},{"key":"34873_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1634\/theoncologist.2013-0341","volume":"19","author":"FM Rizzo","year":"2014","unstructured":"Rizzo, F. M., Cives, M., Simone, V. & Silvestris, F. New insights into the molecular pathogenesis of Langerhans cell histiocytosis. The Oncologist 19, 151\u2013163 (2014).","journal-title":"The Oncologist"},{"key":"34873_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/pbc.25017","volume":"61","author":"SR Vaiselbuh","year":"2014","unstructured":"Vaiselbuh, S. R., Bryceson, Y. T., Allen, C. E., Whitlock, J. A. & Abla, O. Updates on histiocytic disorders. Pediatr. Blood Cancer 61, 1329\u20131335 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"34873_CR5","first-page":"S37","volume":"23","author":"G Kannourakis","year":"1994","unstructured":"Kannourakis, G. & Abbas, A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br. J. Cancer Suppl. 23, S37\u201340 (1994).","journal-title":"Br. J. Cancer Suppl."},{"key":"34873_CR6","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","volume":"120","author":"F Sahm","year":"2012","unstructured":"Sahm, F. et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 120, e28\u2013e34 (2012).","journal-title":"Blood"},{"key":"34873_CR7","doi-asserted-by":"publisher","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","volume":"7","author":"T Satoh","year":"2012","unstructured":"Satoh, T. et al. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS ONE 7, e33891 (2012).","journal-title":"PLoS ONE"},{"key":"34873_CR8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very, G. et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116, 1919\u20131923 (2010).","journal-title":"Blood"},{"key":"34873_CR9","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1378\/chest.12-1917","volume":"143","author":"SA Yousem","year":"2013","unstructured":"Yousem, S. A., Dacic, S., Nikiforov, Y. E. & Nikiforova, M. Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143, 1679\u20131684 (2013).","journal-title":"Chest"},{"key":"34873_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/gcc.22247","volume":"54","author":"DS Nelson","year":"2015","unstructured":"Nelson, D. S. et al. MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54, 361\u2013368 (2015).","journal-title":"Genes Chromosomes Cancer"},{"key":"34873_CR11","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","volume":"124","author":"R Chakraborty","year":"2014","unstructured":"Chakraborty, R. et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 124, 3007\u20133015 (2014).","journal-title":"Blood"},{"key":"34873_CR12","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","volume":"124","author":"NA Brown","year":"2014","unstructured":"Brown, N. A. et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124, 1655\u20131658 (2014).","journal-title":"Blood"},{"key":"34873_CR13","first-page":"4195","volume":"94","author":"RM Egeler","year":"1999","unstructured":"Egeler, R. M., Favara, B. E., van Meurs, M., Laman, J. D. & Claassen, E. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94, 4195\u20134201 (1999).","journal-title":"Blood"},{"key":"34873_CR14","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1371\/journal.pmed.0040253","volume":"4","author":"B Senechal","year":"2007","unstructured":"Senechal, B. et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 4, e253 (2007).","journal-title":"PLoS Med."},{"key":"34873_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.0105-2896.2009.00883.x","volume":"234","author":"RM Egeler","year":"2010","unstructured":"Egeler, R. M., van Halteren, A. G. S., Hogendoorn, P. C. W., Laman, J. D. & Leenen, P. J. M. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunol. Rev. 234, 213\u2013232 (2010).","journal-title":"Immunol. Rev."},{"key":"34873_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/jir.2014.0190","volume":"35","author":"WT Quispel","year":"2015","unstructured":"Quispel, W. T., Stegehuis-Kamp, J. A., Santos, S. J., Egeler, R. M. & van Halteren, A. G. S. Activated conventional T-cells are present in Langerhans cell histiocytosis lesions despite the presence of immune suppressive cytokines. Journal of Interferon & Cytokine Research 35, 831\u2013839 (2015).","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"34873_CR17","doi-asserted-by":"publisher","first-page":"e1084463","DOI":"10.1080\/2162402X.2015.1084463","volume":"5","author":"WT Quispel","year":"2016","unstructured":"Quispel, W. T. et al. The presence of CXCR4+ CD1a+ cells at onset of Langerhans cell histiocytosis is associated with a less favorable outcome. Oncoimmunology 5, e1084463 (2016).","journal-title":"Oncoimmunology"},{"issue":"17","key":"34873_CR18","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1182\/blood-2017-05-782730","volume":"130","author":"Eugenio Antonio Carrera Silva","year":"2017","unstructured":"Carrera Silva, E. A. et al. CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis. Blood, https:\/\/doi.org\/10.1182\/blood-2017-05-782730 (2017).","journal-title":"Blood"},{"key":"34873_CR19","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1084\/jem.20021650","volume":"197","author":"MV Dhodapkar","year":"2003","unstructured":"Dhodapkar, M. V. et al. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J. Exp. Med. 197, 1667\u20131676 (2003).","journal-title":"J. Exp. Med."},{"key":"34873_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2007.02.002","volume":"322","author":"JW Molling","year":"2007","unstructured":"Molling, J. W. et al. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity. Journal of Immunological Methods 322, 70\u201381 (2007).","journal-title":"Journal of Immunological Methods"},{"key":"34873_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1749-6632.2009.04931.x","volume":"1174","author":"N Neparidze","year":"2009","unstructured":"Neparidze, N. & Dhodapkar, M. V. Harnessing CD1d-restricted T cells toward antitumor immunity in humans. Ann. N. Y. Acad. Sci. 1174, 61\u201367 (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"34873_CR22","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","volume":"195","author":"P Sundstr\u00f6m","year":"2015","unstructured":"Sundstr\u00f6m, P. et al. Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-\u03b3. The Journal of Immunology 195, 3472\u20133481 (2015).","journal-title":"The Journal of Immunology"},{"key":"34873_CR23","doi-asserted-by":"crossref","unstructured":"Ling, L. et al. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients. Sci. Rep. 6, (2016).","DOI":"10.1038\/srep20358"},{"key":"34873_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/mpo.2950210507","volume":"21","author":"M Alaibac","year":"1993","unstructured":"Alaibac, M. & Chu, A. C. T-lymphocytes bearing the gamma delta T-cell receptor in cutaneous lesions of Langerhans\u2019 cell histiocytosis. Med. Pediatr. Oncol. 21, 347\u2013349 (1993).","journal-title":"Med. Pediatr. Oncol."},{"key":"34873_CR25","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","volume":"184","author":"CE Allen","year":"2010","unstructured":"Allen, C. E. et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. The Journal of Immunology 184, 4557\u20134567 (2010).","journal-title":"The Journal of Immunology"},{"key":"34873_CR26","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.4049\/jimmunol.1402945","volume":"194","author":"E Carolan","year":"2015","unstructured":"Carolan, E. et al. Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity. The Journal of Immunology 194, 5775\u20135780 (2015).","journal-title":"The Journal of Immunology"},{"key":"34873_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12582","volume":"148","author":"TSC Hinks","year":"2016","unstructured":"Hinks, T. S. C. Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology 148, 1\u201312 (2016).","journal-title":"Immunology"},{"key":"34873_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/sji.12585","volume":"86","author":"A Mekinian","year":"2017","unstructured":"Mekinian, A. et al. Mucosal-associated invariant (MAIT) cells are deficient in systemic sclerosis. Scand J Immunol 86, 216\u2013220 (2017).","journal-title":"Scand J Immunol"},{"key":"34873_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/2326-6066.CIR-15-0062","volume":"3","author":"RM McEwen-Smith","year":"2015","unstructured":"McEwen-Smith, R. M., Salio, M. & Cerundolo, V. The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunology Research 3, 425\u2013435 (2015).","journal-title":"Cancer Immunology Research"},{"key":"34873_CR30","doi-asserted-by":"publisher","first-page":"15662","DOI":"10.3390\/molecules181215662","volume":"18","author":"B Anderson","year":"2013","unstructured":"Anderson, B., Teyton, L., Bendelac, A. & Savage, P. Stimulation of natural killer T cells by glycolipids. Molecules 18, 15662\u201315688 (2013).","journal-title":"Molecules"},{"key":"34873_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/icb.2016.35","volume":"94","author":"DG Pellicci","year":"2016","unstructured":"Pellicci, D. G. & Uldrich, A. P. All work and no Id2 makes a dull NKT cell. Immunol. Cell Biol. 94, 619\u2013620 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"34873_CR32","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni.3298","volume":"16","author":"DI Godfrey","year":"2015","unstructured":"Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J. & Moody, D. B. The burgeoning family of unconventional T cells. Nat. Immunol. 16, 1114\u20131123 (2015).","journal-title":"Nat. Immunol."},{"key":"34873_CR33","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1084\/jem.20130958","volume":"210","author":"R Reantragoon","year":"2013","unstructured":"Reantragoon, R. et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. Journal of Experimental Medicine 210, 2305\u20132320 (2013).","journal-title":"Journal of Experimental Medicine"},{"key":"34873_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/sji.12193","volume":"80","author":"J Novak","year":"2014","unstructured":"Novak, J., Dobrovolny, J., Novakova, L. & Kozak, T. The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80, 271\u2013275 (2014).","journal-title":"Scand J Immunol"},{"issue":"5","key":"34873_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/imcb.12021","volume":"96","author":"Nicholas A Gherardin","year":"2018","unstructured":"Gherardin, N. A. et al. Human blood MAIT cell subsets defined using MR1 tetramers. Immunol. Cell Biol. https:\/\/doi.org\/10.1111\/imcb.12021 (2018).","journal-title":"Immunology and Cell Biology"},{"key":"34873_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fimmu.2017.01031","volume":"8","author":"A Kurioka","year":"2017","unstructured":"Kurioka, A. et al. Shared and Distinct Phenotypes and Functions of Human CD161++ V\u03b17.2+ T Cell Subsets. Front Immunol 8, 1031 (2017).","journal-title":"Front Immunol"},{"key":"34873_CR37","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","volume":"9","author":"JR Fergusson","year":"2014","unstructured":"Fergusson, J. R. et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 9, 1075\u20131088 (2014).","journal-title":"Cell Rep"},{"key":"34873_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cyto.2017.05.026","volume":"97","author":"A Morimoto","year":"2017","unstructured":"Morimoto, A. et al. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis. Cytokine 97, 73\u201379 (2017).","journal-title":"Cytokine"},{"key":"34873_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2009.03888.x","volume":"156","author":"AC Chan","year":"2009","unstructured":"Chan, A. C. et al. Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol 156, 238\u2013245 (2009).","journal-title":"Clin Exp Immunol"},{"key":"34873_CR40","first-page":"131","volume":"11","author":"SP Berzins","year":"2011","unstructured":"Berzins, S. P., Smyth, M. J. & Baxter, A. G. Presumed guilty: natural killer T cell defects and human disease. Nature Publishing Group 11, 131\u2013142 (2011).","journal-title":"Nature Publishing Group"},{"key":"34873_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clim.2014.04.004","volume":"153","author":"M Lourda","year":"2014","unstructured":"Lourda, M. et al. Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients. Clin. Immunol. 153, 112\u2013122 (2014).","journal-title":"Clin. Immunol."},{"key":"34873_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/mt.2011.106","volume":"19","author":"TL Peters","year":"2011","unstructured":"Peters, T. L., McClain, K. L. & Allen, C. E. Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions. Mol. Ther. 19, 1433\u20131439 (2011).","journal-title":"Mol. Ther."},{"key":"34873_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nm1694","volume":"14","author":"F Coury","year":"2008","unstructured":"Coury, F. et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 14, 81\u201387 (2008).","journal-title":"Nat. Med."},{"key":"34873_CR44","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.4049\/jimmunol.1700615","volume":"199","author":"M Salio","year":"2017","unstructured":"Salio, M. et al. Activation of human mucosal-associated invariant T cells induces CD40L-dependent maturation of monocyte-derived and primary dendritic cells. The Journal of Immunology 199, 2631\u20132638 (2017).","journal-title":"The Journal of Immunology"},{"key":"34873_CR45","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1182\/blood.V97.5.1241","volume":"97","author":"F Geissmann","year":"2001","unstructured":"Geissmann, F. et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97, 1241\u20131248 (2001).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34873-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:14:43Z","timestamp":1671621283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34873"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34873-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16506"}}